A clinical trial to look at efficacy, safety and tolerability of oral repeat doses of ONO-4053 and the standard Hay Fever treatment Cetirizine in subjects with seasonal allergic rhinitis using an inhalation exposure chamber in Vienna.

Registry ID

EUCTR2012-002273-54

Source registry

EUCTR

Status

Completed

Phase

PHASE2

Sponsor

Ono Pharmaceutical Co. Ltd.

Start date

2012-10-23

Completion date

2013-03-12

Last update

2026-08-16

Conditions

• Allergic Rhinitis

Summary

• To investigate the effect of repeat oral doses of ONO-4053 versus placebo on nasal symptoms (Total Nasal Symptom Score) elicited by allergen chamber challenge in subjects with allergic rhinitis. • To investigate the safety and tolerability of repeat oral doses of ONO-4053 versus placebo in subjects with allergic rhinitis.

Locations

• , , Austria

Related clinical trials

• Study of Yupingfeng Powder Treating Allergic Rhinitis (AR)
• Evaluation of ALLERgen Specific Vaccination of DOG Allergic Patients in Swedish Practice
• Facilitating Surgical Choice in Patient With Chronic Hypertrophic Rhinitis Using a Patient Decision Aid
• EmoTIChealth: Promoting Adolescent Health Through a Serious Game.
• Dietary Intervention on Atopy
• Evaluation of a Digital Tool to Improve Aeroallergen Immunotherapy Adherence. NavigAITme Project

View on source registry